IXJ

iShares Global Healthcare ETF

The administration is now exploring alternative measures, such as federal grants or loans, to encourage the domestic production of critical generic drugs, aiming to reduce reliance on foreign suppliers, including India.

AI's growing role in cancer research, and a new federal push for pediatric oncology, are powering gains in key healthcare ETFs.

The Fabrizio Ward survey of 1,000 voters found 77% of Trump supporters back measles shots and 69% support hepatitis B, while at least 90% of Kamala Harris voters backed all three vaccines.

Medical groups and more than 1,000 health officials have urged Robert F. Kennedy Jr. to resign, warning his vaccine policies are putting public health at risk.

The administration is expected to release findings from a separate semiconductor investigation first, with other high-profile events also contributing to the delay.

Several drugmakers, including AstraZeneca and Eli Lilly, have already pledged major investments in U.S. manufacturing.

The U.S. health department is canceling or scaling back 22 BARDA-backed mRNA projects worth nearly $500 million, shifting funding toward broader vaccine platforms.

The letters laid out specific demands, including matching the lowest global prices for Medicaid patients and ending preferential pricing abroad, while warning that failure to comply would trigger federal action.

The Trump administration is reportedly considering a major restructuring of the FDA’s biologics division, potentially splitting it into separate offices for vaccines and therapeutics.